Springbok Capital Management »

Horizon Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $21M 181k 115.69
2023-06-30 $16M 158k 102.85
2023-03-31 $17M 152k 109.14
2022-12-31 $9.2M 81k 113.80
2022-09-30 $587k 9.5k 61.87
2022-06-30 $1.6M 20k 79.78
2022-03-31 $664k 6.3k 105.15
2021-09-30 $1.2M 11k 109.54
2021-06-30 $729k 7.8k 93.65
2021-03-31 $226k 2.5k 91.87
2020-12-31 $418k 5.7k 73.08
2020-03-31 $319k 11k 29.62
2019-09-30 $5.0k 184 27.17

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Tesla Motors (TSLA)
Activision Blizzard Call Option
Horizon Therapeutics Pub L SHS Call Option
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Consol Energy (CEIX)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Brighthouse Finl (BHF)
Netease Sponsored Ads (NTES)
Bio Rad Labs Cl A (BIO)
Select Sector Spdr Tr Sbi Int-utils Put Option (XLU)
Trip Com Group Ads (TCOM)

View all positions for Springbok Capital Management

Top funds holding Horizon Therapeutics

IFP Advisors
Ronald Blue Trust
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics